Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subtyping for pancreatic cancer precision therapy
Xing Huang, Gang Zhang, Tingbo Liang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 482-494
Closed Access | Times Cited: 24

Showing 24 citing articles:

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
Xing Huang, Gang Zhang, Tianyu Tang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 67
The multiple roles of interferon regulatory factor family in health and disease
Luyao Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Precision treatment of pancreatic ductal adenocarcinoma
Hongyun Wei, He Ren
Cancer Letters (2024) Vol. 585, pp. 216636-216636
Closed Access | Times Cited: 9
MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer
Shi Dong, Xin Li, Chen Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes
Premila D. Leiphrakpam, Sanjib Chowdhury, Michelle Zhang, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access | Times Cited: 1
Bioinformatics analysis reveals novel tumor antigens and immune subtypes of skin cutaneous melanoma contributing to mRNA vaccine development
Ronghua Yang, Jia He, Deni Kang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Deciphering the senescence‐based tumoral heterogeneity and characteristics in pancreatic cancer: Results from parallel bulk and single‐cell transcriptome data
Yeting Lu, Shuo Han, Jing Hu, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access
Pancreatic Tumour Microenvironment and Microenvironment Targeted Therapeutic Approaches
Demet Kaçaroğlu
IntechOpen eBooks (2025)
Closed Access
Pancreatic cancer subtyping - the keystone of precision treatment
Zeyang Fan, Yao Xiao, Yan Du, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma
Qian Huang, Xingyu Peng, Qingqing Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein
Jing Wang, Liping Zheng, Chundong Hu, et al.
Cellular Signalling (2023) Vol. 107, pp. 110661-110661
Open Access | Times Cited: 7
Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models
Åsmund Flobak, Sigrid S. Skånland, Eivind Hovig, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 973-985
Open Access | Times Cited: 12
A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma
Hongkai Zhuang, Chenwei Tang, Lin Han, et al.
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1205-1220
Closed Access | Times Cited: 2
Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer
Hang Sun, Yan Wang, Minghao Sun, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
Jiangang Zhao, Yujie Li, Jingjing Wu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
Jiabin Yang, Liangtang Zeng, Ruiwan Chen, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1442-1442
Open Access | Times Cited: 5
Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer
Chunlu Dong, Haidong Ma, Ningning Mi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Inhibition of DEF‐p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer
Sicong Huang, Jiaqi Yang, Teng Xie, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 1
GCNA-Cluster: A Gene Co-Expression Network Alignment to Cluster Cancer Patients Algorithm for Identifying Subtypes of Pancreatic Ductal Adenocarcinoma
Jing Yang, Zhengshu Lu, Chen Xu, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2023) Vol. 20, Iss. 6, pp. 3556-3566
Closed Access | Times Cited: 3
Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress
Hongyu Wu, Jinwei Li, Jin-Zheng Li, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 2, pp. 142-162
Open Access | Times Cited: 2
A novel staging system derived from natural language processing of pathology reports to predict prognostic outcomes of pancreatic cancer: a retrospective cohort study
Bo Li, Beilei Wang, Pengjie Zhuang, et al.
International Journal of Surgery (2023)
Open Access | Times Cited: 1
Pancreatic Cancer: Nanoparticle Targeted Therapy Via Epidermal Growth Factor Receptor
Vivek Kumar Dwivedi, Shahnawaz Sameem, Mahfoozur Rahman, et al.
(2022), pp. 111-128
Closed Access | Times Cited: 1
The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease
Yangju Fu, Yongbo Zheng
Frontiers in Oncology (2023) Vol. 13
Open Access
Page 1

Scroll to top